Experienced in Sarcoidosis

Dr. Joel Mermis

Intensive Care Medicine
University Of Kansas Hospital Transplant Center
3901 Rainbow Blvd, 
Kansas City, KS 
Experienced in Sarcoidosis
University Of Kansas Hospital Transplant Center
3901 Rainbow Blvd, 
Kansas City, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joel Mermis is an Intensive Care Medicine provider in Kansas City, Kansas. Dr. Mermis is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Thyroidectomy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in KS
Hospital Affiliations
University Of Kansas Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

University of Kansas Hospital Transplant Center
3901 Rainbow Blvd, Kansas City, KS 66160
Call: 913-588-6046
Other Locations
The University of Kansas Hospital
4000 Cambridge St, Kansas City, KS 66160
Call: 913-588-0000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1b Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
A Phase 1b Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Drug
Study Drug: CB-280 Arginase Inhibitor
Study Phase: Phase 1
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

17 Total Publications

Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Journal: The Lancet. Respiratory medicine
Published: October 25, 2024
View All 17 Publications
Similar Doctors
Distinguished in Sarcoidosis
Dr. Mark Hamblin
Intensive Care Medicine
Distinguished in Sarcoidosis
Dr. Mark Hamblin
Intensive Care Medicine

The University Of Kansas Health System's Quivira Medical Pavilion A

12000 W 110th St, 
Overland Park, KS 
 (9.8 miles away)
913-588-6045
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Hamblin is an Intensive Care Medicine provider in Overland Park, Kansas. Dr. Hamblin is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Sarcoidosis, and Bone Marrow Aspiration.

Distinguished in Sarcoidosis
Dr. Lucas Pitts
Intensive Care Medicine
Distinguished in Sarcoidosis
Dr. Lucas Pitts
Intensive Care Medicine

University Of Kansas Hospital Transplant Center

3901 Rainbow Blvd, 
Kansas City, KS 
 (0.1 miles away)
913-588-7750
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lucas Pitts is an Intensive Care Medicine provider in Kansas City, Kansas. Dr. Pitts is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Sarcoidosis, Acute Interstitial Pneumonia, Hypersensitivity Pneumonitis, Endoscopy, and Bone Marrow Aspiration.

Advanced in Sarcoidosis
Dr. Sahil Pandya
Intensive Care Medicine
Advanced in Sarcoidosis
Dr. Sahil Pandya
Intensive Care Medicine

Miller Building Eye Care And Optical Shop

Kansas City, KS 
 (3.9 miles away)
913-588-6045
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sahil Pandya is an Intensive Care Medicine provider in Kansas City, Kansas. Dr. Pandya is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Metastases.

VIEW MORE SARCOIDOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mermis's expertise for a condition
ConditionClose
  • Elite
  • Cystic Fibrosis
    Dr. Mermis is
    Elite
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Distinguished
  • Secondary Immunodeficiency (SID)
    Dr. Mermis is
    Distinguished
    . Learn about Secondary Immunodeficiency (SID).
    See more Secondary Immunodeficiency (SID) experts
  • Advanced
  • Bronchiectasis
    Dr. Mermis is
    Advanced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Lung Metastases
    Dr. Mermis is
    Advanced
    . Learn about Lung Metastases.
    See more Lung Metastases experts
  • Newborn Jaundice
    Dr. Mermis is
    Advanced
    . Learn about Newborn Jaundice.
    See more Newborn Jaundice experts
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Mermis is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Bronchogenic Cyst
    Dr. Mermis is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • Bullae
    Dr. Mermis is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
  • Chronic Cough
    Dr. Mermis is
    Experienced
    . Learn about Chronic Cough.
    See more Chronic Cough experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Mermis is
    Experienced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Collapsed Lung
    Dr. Mermis is
    Experienced
    . Learn about Collapsed Lung.
    See more Collapsed Lung experts
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.